Evaluation of an extended period of use for preserved eye drops in hospital practice

British Journal of Ophthalmology

Volumn 82, Issue 5, 1998, Pages 473-475

  Livingstone, D J ^a   Hanlon, G W ^b   Dyke, S ^b  

^a UK   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS;

ARTICLE; BACTERIUM CONTAMINATION; COST CONTROL; FUNGUS CULTURE; GENERAL HOSPITAL; HEALTH CARE COST; LONG TERM CARE; PRIORITY JOURNAL;

EID: 0031783608     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.5.473     Document Type: Article

References (10)

1. Jolly S, ed. British pharmaceutical codex. 8th ed. London: Pharmaceutical Press, 1963 (Suppl) 1966:77.
2. Department of Health and Social Security. Preservation of sterility in ophthalmic preparations in hospitals. Health Service Circular HSC (IS) 122. London: DHSS, 1975.
3. Barkman R, Germanis M, Karpe G, et al. Preservatives in eye drops. Acta Ophthalmol 1969;47:461-75.
4. Wilson J. Eye drops - time for a fresh look at guidelines. Pharm J 1990; 3 November: 594.
5. DuBois SK, Pinney RJ, Davison AL. Investigation of the levels of bacterial contamination in used eye drops. Pharm J 1989; 30 September:R39.
6. Douch MM, Davison AL. An investigation into the in-use contamination of Timolol eye drops used on the wards. J Hosp Pharm Practice 1992;2:483-6.
7. Guest H, Hanlon GW, Livingstone DJ. Microbial evaluation of preservative-free eye drops in multiple application containers. Pharm J 1990;245:R17.
8. Harte V, O'Hanrahan M, Timoney R. Microbial contamination in residues of ophthalmic preparations. Int J Pharmaceut 1978;1:165-71.
9. Rosebury T. Microorganisms indigenous to man. New York: McGraw-Hill, 1962:318-23.
10. Lund W, ed. The pharmaceutical codex. 12th ed. London: Pharmaceutical Press, 1994:164-5.